Antara is responsible for the execution of Oxford’s European life sciences strategy. This requires

management and coordination across investment, development, marketing and leasing, financing,

strategic asset management and managing key stakeholder relationships to realise business plans and

deliver returns.

Antara has 16 years of real estate experience having started her career as a development manager

working across the development lifecycle from inception to delivery and stabilisation, across sectors,

clients and project types and sizes. In her 9 years (and counting!) at Oxford, Antara started out on the

development team, playing an instrumental role in development projects across the UK, Paris and Berlin

as well as building out and leading an incredibly talented development team. Antara then took on a new

challenge, overseeing the European residential strategy at Oxford before shifting her focus to life

sciences.

Since 2021, Antara has served as an Independent Committee Member (NED) on the Group Investment

Committee at Hyde Group, one of the largest housing associations in England, a role she took on during

her time on the European residential team at Oxford.

Antara holds a BA (Hons) in Philosophy, Politics and Economics from The University of Oxford and is a

Chartered Surveyor (MRICS).

Antara believes that beaten paths are for beaten people. She is relentlessly curious and optimistic and is

particularly enthusiastic about energising capable teams and channeling expertise, to find creative

solutions to seemingly impossible challenges.

Under Henry’s leadership, King’s Cross is bringing forward a range of office spaces to lease. These include space at Western Transit Shed, Two Pancras Square and The Jellicoe, where the neighbourhood is delivering new purpose-built flexible workspace in partnership with Fora (formerly The Office Group) as it continues to evolve its product offer to office occupiers.

Henry brings almost two decades of experience and leadership across commercial real estate investment, development, leasing and asset management, including roles as Head of UK and Vice President for Offices, Retail and Life Sciences at Oxford Properties Group. During his almost 10-year tenure, he played a pivotal role in growing the company’s office and retail platform in the UK.

Richard brings over 17 years’ investment track record, having transacted in excess of £2 billion in UK real estate. Richard’s primary responsibility is expansion of the Knowledge Factory portfolio and asset management, utilising his strong network of contacts with UK institutions, property companies, occupiers and brokers.

Chris has more than two decades of expertise in supporting private and public sector organisations across the built environment and infrastructure sectors. He has led LCA teams on a variety of complex projects, providing guidance across communications, from community engagement and media relations to public affairs and social media.

He has worked on a number of high profile life science projects over the past few years including British Land’s redevelopment of Euston Tower and Stanhope and Guy’s & St Thomas’s Foundation life sciences-led mixed-use scheme at Royal Street in Lambeth.

Mairi leads ecosystem development for Canary Wharf Life Sciences. Canary Wharf is already home to over 40 life science and healthcare businesses and CL2/CL3 labs. We aspire to become a globally recognised life science ecosystem in East London.

Mairi has a wealth of experience in early-stage tech fundraising, project management and outward facing relationship building (public and private sector). She began her career in major government-sponsored infrastructure projects before moving into the innovation and entrepreneurship landscape. As Head of Operations for a venture capital backed bio-tech start-up, she gained broad business experience bringing a product to market and fundraising both in the U.K. and abroad. Through her roles within the Catapult Network, Smart Specialisation Hub, Innovate UK’s Knowledge Transfer Network and most recently, establishing and leading Kadan’s national ecosystem strategy, Mairi has built a deep understanding of how to link the research, commercial and investment worlds.

Oli King is the Development and Leasing Director at Stevenage Bioscience Catalyst (SBC) where he supports the growing cluster of 45 therapeutics companies and continues to lead on all disposals across the asset portfolio.

Prior to SBC, Oli has over 20 years’ experience in the Central London office market advising on development, refurbishment, leasing strategy, acquisitions, and disposals. Previous clients include Procter & Gamble, Microsoft, Giorgio Armani & Moet Hennessy.

Suketu Shah serves as the Head of Life Sciences - Property and Asset Management at JLL, where he brings over 17 years of combined expertise in Life Sciences and Real Estate.

He specializes in comprehensive life sciences consultancy and oversees property management for Life Science facilities. Suketu has demonstrated exceptional proficiency serving organizations involved in drug discovery, contract research (CRO), contract drug manufacturing (CDMO), and research and development (R&D). His technical knowledge extends to cleanroom management, GMP facilities, and properties housing Med-tech and Agri-tech companies.

Suketu's notable achievements include designing and developing multiple Incubator facilities across the UK, establishing state-of-the-art shared access laboratories within the AstraZeneca campus at Alderley Park, and managing a 300,000 sqft Life Sciences buildings across multiple sites in Nottingham.

What distinguishes Suketu is his ability to understand scientific and laboratory requirements and translate these needs into optimal facilities. Having worked directly in laboratories, he maintains a greater understanding of the balance between functionality and innovation in life science spaces while fostering collaborative communities that advance research initiatives.

Stewart has spent more than 20 years at Reef and is involved in the delivery of many complex developments and investments totalling several billion pounds in end value. Stewart is proud of Reef’s strategic partnerships and this, together with an innovative approach to design, funding and delivery, has positively influenced the team’s ability to deliver vibrant and sustainable places.

Stewart is passionate about collaborating with a range of organisations such as research, academic and healthcare institutions, together with funding, occupier and local authority partners that are critical to the success of any project.

He has spent the last ten years focusing on the healthcare, science and innovation sectors, with all projects underpinned by placemaking excellence. Within his role as CEO of Reef + Partners, he is actively engaged with project teams across a range of developments.

Peter is leading a programme for the redevelopment of the Guy’s and St Thomas’ campuses and community facilities in Lambeth and Southwark, with a combined capital value of more than £2bn over the next decade. Until November 2017 he was the Director of Healthcare Projects for John Laing, a leading international investor in economic and social infrastructure which delivered more than 20 major healthcare Public-Private Partnership projects and over 40 clinics and primary care facilities during his time there.

He has worked on the development of public infrastructure since 1989 and has substantial experience in the successful structuring and delivery of a diverse range of project financing, PPP and development projects in the healthcare, water and transportation sectors in the UK and overseas. Since 2001 he has managed the development of healthcare projects with a capital value exceeding £2bn.

Peter is a Chartered Civil Engineer and a Fellow of the Institution of Civil Engineers, and has served two full terms as a Non-Executive Director of the Oxford University Hospitals NHS Foundation Trust. He also led the development of a UN standard for the use of PPP in the healthcare sector for the United Nations Economic Commission for Europe, and remains a member of the United Nations PPP Business Advisory Board.

Ed is the interim Managing Director of Cambridge Biomedical Campus Ltd which

represents some of the major businesses located on the campus which is the

biggest in Europe. These include Astra Zenica, the University of Cambridge,

Abcam (Danaher), the MRC Lab of Molecular Biology, Cambridge University

Hospital Trust and the Royal Papworth Hospital. Ed’s career was built in Local

Government as a Director of Planning and Regeneration at Camden, Lambeth

and Westminster before founding consultancy EW&A which works with a range of

clients including CBC Ltd, Arup and British Land, LabTech, Bouygues/Linkcity and

Moorfields. At Camden Ed led on the negotiations to secure the arrival of the

Francis Crick Institute and worked with Argent to develop their scheme at Kings

Cross.

Dr Angela Kukula is CEO of MedCity, and Director of Life Sciences at London & Partners

where she leads a team of professionals championing the development of the life sciences

sector in London, promoting London as the premier global destination for life science, and

supporting high growth life sciences companies to make their home in London and to

thrive and grow.

Angela has worked in the London Life Science ecosystem for over 12 years, most recently

as Commercial Director at the Chelsea and Westminster hospital and prior to that as

Director of Business and Innovation at the Institute of Cancer Research.

She is an internationally recognised technology transfer specialist. She sits on the Board

of Oxford University Innovation and is a past chair of Knowledge Exchange UK (then

PraxisAuril), the professional body for technology transfer in the UK.

She is passionate about supporting the next generation of life science leaders through her

work as governor of two London secondary schools, one of which is a life sciences

specialist academy.

Angela completed her undergraduate Bachelor degree in Biochemistry at the University of

Oxford, and her PhD in Molecular Immunology and Genetics at the Institute of Child

Health, University of London. Angela also has an MBA specialising in Technology

Management, and a LLM in Commercial Law.

Josh Krayger serves on the leadership team for HDR’s global health market sector. In this role, he helps to establish and execute strategies that fuel growth of the practice across the world. With a strong background in graphic design, marketing and strategy, Josh has played critical roles in the organization over the past 20+ years – leading through evolving shifts related to mergers, new market strategies, and organic expansion. He brings a passion for driving accountability and efficiency at all levels of the business, while focusing on identifying cross-sector growth opportunities for the organization.

Paul is the Commercial Director at specialist placemaking and commercial landscaping contractor S&C Slatter. Since joining the company in 2013, Paul has been instrumental in the integration of acquired companies and the development of an in-house Professional Services team, resulting in a comprehensive, one-stop, integrated solution to create places that inspire communities, facilitate wellbeing, and improve biodiversity. More recently, Paul has successfully overseen the company’s diversification into the Industrial and Logistics sector, working with a range of consultants, architects, and developers to deliver innovative projects, resulting in a prestigious Fitwel Award for Winnersh Triangle Business Park.”

Chris has extensive experience in application technology sales, particularly within the construction sector. With a keen focus on driving sales growth, he plays a key role in supporting our agents and resellers, helping to accelerate our global sales reach.